Mouse Allergen and Asthma Intervention Trial (MAAIT)
|ClinicalTrials.gov Identifier: NCT01251224|
Recruitment Status : Completed
First Posted : December 1, 2010
Last Update Posted : March 16, 2017
|Condition or disease||Intervention/treatment||Phase|
|Asthma Mouse Allergy Mouse Allergen Exposure||Other: Integrated Pest Management Other: Education||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||361 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Mouse Allergen and Asthma Intervention Trial|
|Study Start Date :||November 2010|
|Actual Primary Completion Date :||September 2016|
|Actual Study Completion Date :||September 2016|
Active Comparator: Education Group
This group will receive IPM education at baseline, and then the full IPM intervention after completing the study.
This group will receive education about mouse IPM.
Experimental: IPM Group
This group will receive the full IPM intervention at baseline.
Other: Integrated Pest Management
The IPM intervention will include professional mouse abatement, two HEPA filters, targeted cleaning, education about IPM, and allergen-proof mattress and pillow encasements. The intervention will be delivered at baseline to the IPM Group, and then repeated if recurrent or persistent mouse infestation is present.
- change in asthma symptoms [ Time Frame: 0, 3, 6, 9, 12 months ]days of asthma symptoms
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01251224
|United States, Maryland|
|Baltimore, Maryland, United States, 21287|
|United States, Massachusetts|
|Boston, Massachusetts, United States, 02210|